These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28771788)

  • 1. HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues.
    Qaiser T; Mukherjee A; Reddy Pb C; Munugoti SD; Tallam V; Pitkäaho T; Lehtimäki T; Naughton T; Berseth M; Pedraza A; Mukundan R; Smith M; Bhalerao A; Rodner E; Simon M; Denzler J; Huang CH; Bueno G; Snead D; Ellis IO; Ilyas M; Rajpoot N
    Histopathology; 2018 Jan; 72(2):227-238. PubMed ID: 28771788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.
    Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S
    J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning Where to See: A Novel Attention Model for Automated Immunohistochemical Scoring.
    Qaiser T; Rajpoot NM
    IEEE Trans Med Imaging; 2019 Nov; 38(11):2620-2631. PubMed ID: 30908205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-automated analysis of HER2 immunohistochemistry in invasive breast carcinoma using whole slide images: utility for interpretation in clinical practice.
    Liao CC; Bakoglu N; Cesmecioglu E; Hanna M; Pareja F; Wen HY; D'Alfonso TM; Brogi E; Yagi Y; Ross DS
    Pathol Oncol Res; 2024; 30():1611826. PubMed ID: 39267995
    [No Abstract]   [Full Text] [Related]  

  • 5. Fully Automated Artificial Intelligence Solution for Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Scoring in Breast Cancer: A Multireader Study.
    Krishnamurthy S; Schnitt SJ; Vincent-Salomon A; Canas-Marques R; Colon E; Kantekure K; Maklakovski M; Finck W; Thomassin J; Globerson Y; Bien L; Mallel G; Grinwald M; Linhart C; Sandbank J; Vecsler M
    JCO Precis Oncol; 2024 Oct; 8():e2400353. PubMed ID: 39393036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study.
    Yue M; Zhang J; Wang X; Yan K; Cai L; Tian K; Niu S; Han X; Yu Y; Huang J; Han D; Yao J; Liu Y
    Virchows Arch; 2021 Sep; 479(3):443-449. PubMed ID: 34279719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Histopathology; 2019 May; 74(6):917-924. PubMed ID: 30585668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays.
    Laurinaviciene A; Dasevicius D; Ostapenko V; Jarmalaite S; Lazutka J; Laurinavicius A
    Diagn Pathol; 2011 Sep; 6():87. PubMed ID: 21943197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-assisted assessment of the human epidermal growth factor receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls.
    Hall BH; Ianosi-Irimie M; Javidian P; Chen W; Ganesan S; Foran DJ
    BMC Med Imaging; 2008 Jun; 8():11. PubMed ID: 18534031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer.
    Masmoudi H; Hewitt SM; Petrick N; Myers KJ; Gavrielides MA
    IEEE Trans Med Imaging; 2009 Jun; 28(6):916-25. PubMed ID: 19164073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma.
    Feng M; Deng Y; Yang L; Jing Q; Zhang Z; Xu L; Wei X; Zhou Y; Wu D; Xiang F; Wang Y; Bao J; Bu H
    Diagn Pathol; 2020 May; 15(1):65. PubMed ID: 32471471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis.
    Sun H; Kang EY; Chen H; Sweeney KJ; Suchko M; Wu Y; Wen J; Krishnamurthy S; Albarracin CT; Ding QQ; Foo WC; Sahin AA
    Breast Cancer Res Treat; 2024 Jun; 205(2):403-411. PubMed ID: 38441847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer.
    Shamai G; Binenbaum Y; Slossberg R; Duek I; Gil Z; Kimmel R
    JAMA Netw Open; 2019 Jul; 2(7):e197700. PubMed ID: 31348505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a HER2-Low Focused Immunohistochemical Scoring System With High-Interobserver Concordance: The Australian HER2-Low Breast Cancer Concordance Study.
    Farshid G; Armes J; Dessauvagie B; Gilhotra A; Kumar B; Mahajan H; Millar E; Pathmanathan N; Snell C
    Mod Pathol; 2024 Aug; 37(8):100535. PubMed ID: 38852812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital validation of breast biomarkers (ER, PR, AR, and HER2) in cytology specimens using three different scanners.
    Salama AM; Hanna MG; Giri D; Kezlarian B; Jean MH; Lin O; Vallejo C; Brogi E; Edelweiss M
    Mod Pathol; 2022 Jan; 35(1):52-59. PubMed ID: 34518629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated segmentation of cell membranes to evaluate HER2 status in whole slide images using a modified deep learning network.
    Khameneh FD; Razavi S; Kamasak M
    Comput Biol Med; 2019 Jul; 110():164-174. PubMed ID: 31163391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence for assisted HER2 immunohistochemistry evaluation of breast cancer: A systematic review and meta-analysis.
    Wu S; Li X; Miao J; Xian D; Yue M; Liu H; Fan S; Wei W; Liu Y
    Pathol Res Pract; 2024 Aug; 260():155472. PubMed ID: 39053133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomas.
    Nassar A; Cohen C; Albitar M; Agersborg SS; Zhou W; Lynch KA; Heyman ER; Lange H; Siddiqui MT
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):212-7. PubMed ID: 21475038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tissue decalcification on the quantification of breast cancer biomarkers by digital image analysis.
    Gertych A; Mohan S; Maclary S; Mohanty S; Wawrowsky K; Mirocha J; Balzer B; Knudsen BS
    Diagn Pathol; 2014 Nov; 9():213. PubMed ID: 25421113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of a HER2 testing algorithm specific for p53-abnormal endometrial cancer.
    Vermij L; Singh N; Leon-Castillo A; Horeweg N; Oosting J; Carlson J; Smit V; Gilks B; Bosse T
    Histopathology; 2021 Oct; 79(4):533-543. PubMed ID: 33835523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.